All relevant data are within the paper.

Introduction {#sec004}
============

Many interventional cardiologists have adopted transradial catheterization (TRC) the last decade. The first TRC was performed by Campeau in 1989\[[@pone.0185404.ref001]\], and the first coronary stent was implanted via radial artery by Kiemeneij and Laarman in 1993\[[@pone.0185404.ref002]\]. Nowadays, the rate of transradial access (TRA) for percutaneous coronary interventions (PCI) is higher than transfemoral in many centers although the prevalence is higher in Asia and Europe than in the USA\[[@pone.0185404.ref003],[@pone.0185404.ref004]\]. Compared to the femoral artery, TRA offers lower rate of complications such as bleeding\[[@pone.0185404.ref005]\] and even death\[[@pone.0185404.ref006]\]. However, the radial artery (RA) is smaller than the femoral artery\[[@pone.0185404.ref003]\], and TRA is associated with a higher prevalence of acute injuries and chronic intimal changes \[[@pone.0185404.ref007],[@pone.0185404.ref008]\]. RA occlusions rate is usually low and remain mostly asymptomatic \[[@pone.0185404.ref009]\]. Previous studies investigated qualitative RA vessel wall changes after TRC in a non-serial manner. A greater thickness of the RA intimal layer was reported in patients with a history of TRC\[[@pone.0185404.ref008],[@pone.0185404.ref010]\]. Frequency-domain optical coherence tomography (FD-OCT) uses near-infrared light for tissue imaging and has a spatial resolution close to 10 microns\[[@pone.0185404.ref011]\]. For RA vessel wall imaging, OCT is currently the best option to assess discreet changes of the RA wall intimal layer. Because of missing prospective data, the aim of this study was to perform first prospective serial FD-OCT study of the RA after first-time transradial PCI in consecutive patients.

Methods {#sec005}
=======

Patient group {#sec006}
-------------

One hundred consecutive patients were included in the project, as a part of larger group of patients (140 subjects) enrolled into a study focusing on OCT analysis of the coronary vessels in patients with the diagnosis of myocardial infarction without ST segment elevation (nSTEMI). The following inclusion criteria were applied: diagnosis of nSTEMI, first-in-life transradial coronary catheterization, and PCI during the index procedure. Exclusion criteria included myocardial infarction with ST segment elevation (STEMI), left main coronary artery lesion, renal insufficiency with creatinine level above 150umol/l, acute heart failure, and refusal to sign the informed consent. Due to the inclusion criterion of transradial catheterization, the patients with radial artery occlusion were excluded as well. 2 patients with occluded RA at follow-up were excluded from this analysis due to unavailability of the follow-up RA OCT pullback. All patients signed written informed consent. The project was approved by the local Ethics Committee of University Hospital Brno (Brno, Czech Republic).

Coronary angiography and PCI procedure {#sec007}
--------------------------------------

Cardiac catheterization was performed in accordance with the local medical standards in an 24/7 tertiary PCI center. The center has wide experience with transradial catheterizations and interventions with a 97% rate of transradial procedures in 2014. All the procedures were performed via 6F *Radiofocus Introducer II* kit (Terumo, Japan) with an intravascular sheath length of 7 cm. The RA was punctured with the kit according to local standards, using micropuncture technique with metallic entry needle and spring mini guidewire. A vasodilating drug (typically 2.5mg of verapamil) was administered in all cases, no other drugs were allowed. Solely 6F guide catheters were used for the coronary interventions. Unfractionated heparin with the target ACT ≥250 was used for the anticoagulation.

OCT procedure protocol {#sec008}
----------------------

After the index coronary angiography and subsequent PCI, OCT of the RA was performed. The standard coronary wire and OCT catheter were placed in the radial artery through the 6F guiding catheter and the guiding catheter was pulled out from the radial sheath. Overall, 3cm of the sheath was withdrawn from the artery (distally), leaving 4cm inside the RA. An X-ray contrast ruler was used to identify the start of OCT imaging and pullback 8cm proximal to the actual sheath tip position. From that point, OCT pullback recording was performed using a 100% contrast fluid to flush the vessel. The standardized length of the pullback was 54mm ([Fig 1](#pone.0185404.g001){ref-type="fig"}). We used the *Dragonfly Duo catheter* and *Optis Ilumien OCT system* (St.Jude, Minneapolis, MN, USA) to perform the OCT procedure. An 2,5mg of verapamil through the sheath was administered before the OCT run. The puncture site was covered with a compress band for two hours to allow hemostasis after the procedure. The standard data acquisition speed was 18mm per second, getting high resolution data from the vessel in 3 seconds (for the 54mm pullback record length).

![Optical coherence tomography of RA---procedure scheme.\
Legend: A-Sheath tip position during the OCT procedure, B-Original sheath tip position during the PCI, C-Start position of the OCT probe.](pone.0185404.g001){#pone.0185404.g001}

The procedure was repeated 9 months after the index procedure during follow-up coronary catheterization. The same OCT protocol as described above was used.

OCT analysis {#sec009}
------------

OCT images of the entire 54 mm segment for each patient were analyzed offline manually by two experienced OCT analysts ([Fig 2](#pone.0185404.g002){ref-type="fig"}) at baseline and follow-up. The lumen border and intima-media border was segmented every 3 mm. Simpson's rule was applied to create a volumetric model of lumen and intimal layer of the radial artery. This model was used to compare the baseline and follow-up volumes of both the lumen and the intimal layer of the radial artery. If some frames were not of sufficient quality for evaluation, the analysis was normalized for the standard length of 54mm. The percentage of analysed frames was 94.7% both in baseline and follow-up pullbacks ([Table 1](#pone.0185404.t001){ref-type="table"}). An analysis of factors affecting the volume changes was performed. In 4 patients, the quality of baseline and/or follow-up OCT was not suitable for analysis because of the insufficient blood wash-out. These patients were not included in the analysis.

10.1371/journal.pone.0185404.t001

###### Evaluability of artery volumes (N = 96).

![](pone.0185404.t001){#pone.0185404.t001g}

                                     Mean ± SD         Median (min-max)
  ---------------------------------- ----------------- ------------------------
  **Baseline measurement**                             
  **Evaluable part of artery (%)**   **90.4 ± 12.3**   **94.7 (52.6; 100.0)**
  Number of invalid frames           **1.8 ± 2.3**     **1.0 (0.0; 9.0)**
  **Follow-up measurement**                            
  **Evaluable part of artery (%)**   **89.4 ± 13.7**   **94.7 (47.4; 100.0)**
  **Number of invalid frames**       **2.0 ± 2.6**     **1.0 (0.0; 10.0)**

![Representative OCT cross-section frame of the radial artery and its analysis.\
Legend: A-intimal layer, B-media, C-adventitia.](pone.0185404.g002){#pone.0185404.g002}

Statistical analysis {#sec010}
--------------------

Standard descriptive statistical methods were applied in the analysis; absolute and relative frequencies for categorical variables and median with 5th-95th percentile range for continuous variables. Statistical significance of differences between various subgroups of patients in baseline and follow-up measurements was tested using a non-parametric Mann-Whitney U test and Kruskal-Wallis test. Intra-individual differences in arterial volumes were assessed using a Wilcoxon signed-rank test. Influence of duration of catheterization on change of volume was tested by Mann-Whitney U test. Correlation between duration of catheterization and change of volume was tested by Pearson's correlation coefficient. Statistical analyses were computed using SPSS 22.0.0.1 (IBM Corporation, 2014).

Results {#sec011}
=======

Radial artery OCT was well tolerated by patients with a general mild discomfort in the forearm during the contrast flush, but no clinically significant adverse events occurred.

Overall, 96 RA data records were of sufficient quality for the analysis. The median age of the group was 66.5 years. More men (67.7%) than women were enrolled. The baseline characteristics of the patient population have been listed in [Table 2](#pone.0185404.t002){ref-type="table"}.

10.1371/journal.pone.0185404.t002

###### Baseline characteristics.

![](pone.0185404.t002){#pone.0185404.t002g}

  Characteristics                                  N (%) or median (5^th^-95^th^ percentile)
  ----------------------------- ------------------ -------------------------------------------
  **Gender**                    Man                65 (67.7%)
  Woman                         31 (32.3%)         
  **Age**                       (N = 96)           66.5 (45.0; 80.7)
  **Body-mass index**           (N = 92)           28.2 (23.1; 37.1)
  **Hypertension**                                 65 (67.7%)
  **Dyslipidemia**                                 31 (32.3%)
  **Diabetes mellitus**                            33 (34.4%)
  **Peripheral vasculopathy**                      4 (4.2%)
  **Smoking**                   Smoker             26 (27.7%)
  Former smoker                 29 (30.9%)         
  Never smoked                  39 (41.5%)         
  **Alcohol**                   ≥ 1 drink / week   14 (14.9%)
  ≥ 1 drink / month             33 (35.1%)         
  \< 1 drink / month            47 (50.0%)         
  **Creatinine (μmol/l)**       (N = 82)           87.5 (52.0; 118.0)

Irrespective of the fact that 54mm of artery was imaged in each patient, distributions of intimal layer volume were relatively wide, from 20mm^3^ to 80mm^3^ ([Fig 3](#pone.0185404.g003){ref-type="fig"}). Similarly, distributions of lumen volume were also wide, from 200mm^3^ to 800mm^3^ ([Fig 4](#pone.0185404.g004){ref-type="fig"}).

![Distributions of RA intimal layer volume in baseline and follow-up measurements.](pone.0185404.g003){#pone.0185404.g003}

![Distributions of RA luminal volume in baseline and follow-up measurements.](pone.0185404.g004){#pone.0185404.g004}

Median intimal layer volume at baseline was 33.9mm^3^ (19.0; 69.4) versus 39.0mm^3^ (21.7; 72.6) measured 9 months later. This difference of 3.0mm^3^ (-9.4; 21.3) was highly statistically significant (p\<0.001, [Table 3](#pone.0185404.t003){ref-type="table"}). The intimal volume increased in 66.7% of patients; no change or decreased volume occurred in 33.3% of patients ([Table 4](#pone.0185404.t004){ref-type="table"}, [Fig 5](#pone.0185404.g005){ref-type="fig"}). Median lumen volume at baseline was 356.3mm^3^ (227.8; 645.3) versus 304.7mm^3^ (186.1; 582.7) 9 months later. The difference of -54.0mm^3^ (-210.6; 87.2) was highly statistically significant (p\<0.001, [Table 3](#pone.0185404.t003){ref-type="table"}). The lumen volume decreased in 79.2% of patients; there was no change or increased volume in 20.8% of patients ([Table 4](#pone.0185404.t004){ref-type="table"}, [Fig 6](#pone.0185404.g006){ref-type="fig"}).

10.1371/journal.pone.0185404.t003

###### RA arterial wall and lumen changes.

![](pone.0185404.t003){#pone.0185404.t003g}

                                              N    Baseline[^1^](#t003fn001){ref-type="table-fn"}   Follow-up[^1^](#t003fn001){ref-type="table-fn"}   Difference[^1^](#t003fn001){ref-type="table-fn"}   p
  ------------------------------------------- ---- ------------------------------------------------ ------------------------------------------------- -------------------------------------------------- --------------
  **Arterial wall volume (mm**^**3**^**)**    96   33.9 (19.0; 69.4)                                39.0 (21.7; 72.6)                                 3.0 (-9.4; 21.3)                                   **\< 0.001**
  **Arterial lumen volume (mm**^**3**^**)**   96   356.3 (227.8; 645.3)                             304.7 (186.1; 582.7)                              -54.0 (-210.6; 87.2)                               **\< 0.001**

^1^ Median (5^th^-95^th^ percentile);

10.1371/journal.pone.0185404.t004

###### Change of volume (N = 96).

![](pone.0185404.t004){#pone.0185404.t004g}

  Volume change    Increase     Decrease
  ---------------- ------------ ------------
  Intima layer     64 (66.7%)   32 (33.3%)
  Arterial lumen   20 (20.8%)   76 (79.2%)

![Change in the volume of intima layer of the arterial wall in individual patients (mm^3^).](pone.0185404.g005){#pone.0185404.g005}

![Change in the volume of arterial lumen in individual patients (mm^3^).](pone.0185404.g006){#pone.0185404.g006}

Analysis of multiple factors affecting intimal and lumen volume changes was performed (gender, age, body-mass index, clinical risk factors and duration of catheterization). No significant risk factor associated with the intimal and lumen volume changes was identified (Tables [5](#pone.0185404.t005){ref-type="table"} and [6](#pone.0185404.t006){ref-type="table"}). Likewise, there was no correlation between duration of catheterization and change of volume (Tables [7](#pone.0185404.t007){ref-type="table"} and [8](#pone.0185404.t008){ref-type="table"}).

10.1371/journal.pone.0185404.t005

###### Influence of risk factors on RA arterial wall changes.

![](pone.0185404.t005){#pone.0185404.t005g}

                                             N                   Arterial wall volume                       
  ----------------------- ------------------ ------------------- ---------------------- ------------------- -------------------
  **Gender**              Man                65                  36.5 (22.2; 69.7)      41.7 (25.5; 69.1)   4.3 (-9.8; 18.2)
  Woman                   31                 30.4 (15.9; 49.1)   34.5 (18.3; 72.6)      2.0 (-7.2; 27.2)    
                          **p**                                                                             **0.664**
  **Age**                 \< 60              29                  26.6 (16.5; 69.0)      28.6 (21.7; 60.0)   2.9 (-12.8; 19.2)
  60--69                  38                 35.6 (19.2; 58.4)   39.5 (19.9; 64.6)      1.8 (-9.8; 19.6)    
  ≥ 70                    29                 36.4 (22.0; 77.1)   44.4 (22.5; 84.0)      7.1 (-8.1; 27.2)    
                          **p**                                                                             **0.307**
  **Body-mass index**     \< 25              12                  25.8 (15.9; 43.3)      33.0 (17.4; 59.9)   7.9 (-4.7; 23.6)
  25--29                  48                 36.4 (19.8; 69.7)   41.8 (24.1; 69.1)      3.7 (-8.1; 18.2)    
  ≥ 30                    32                 34.3 (19.1; 58.4)   35.0 (20.5; 75.0)      2.4 (-12.8; 27.2)   
                          **p**                                                                             **0.368**
  **Hypertension**        Yes                65                  34.7 (19.2; 69.7)      42.2 (22.7; 75.0)   4.3 (-8.7; 19.6)
  No                      31                 30.4 (16.5; 52.7)   31.7 (21.7; 60.0)      2.3 (-12.6; 21.8)   
                          **p**                                                                             **0.692**
  **Dyslipidemia**        Yes                31                  34.1 (22.1; 77.1)      38.7 (22.7; 84.0)   4.7 (-8.1; 19.2)
  No                      65                 33.7 (18.4; 59.4)   39.3 (21.7; 69.1)      2.7 (-9.8; 21.8)    
                          **p**                                                                             **0.848**
  **Diabetes mellitus**   Yes                33                  36.4 (19.0; 69.7)      43.3 (22.7; 75.0)   4.8 (-9.8; 27.2)
  No                      63                 33.3 (19.1; 69.0)   36.1 (21.7; 60.0)      2.2 (-9.3; 18.2)    
                          **p**                                                                             **0.159**
  **Smoking**             Smoker             26                  33.2 (18.4; 55.7)      38.2 (23.7; 63.4)   6.9 (-9.3; 19.2)
  Former smoker           29                 37.1 (23.8; 77.1)   39.9 (26.7; 84.0)      2.9 (-9.4; 21.3)    
  Never smoked            39                 33.7 (19.0; 59.4)   38.7 (18.3; 69.1)      1.5 (-8.1; 23.6)    
                          **p**                                                                             **0.707**
  **Alcohol**             ≥ 1 drink / week   14                  32.5 (12.8; 59.4)      40.7 (19.9; 63.4)   6.7 (-8.7; 21.8)
  ≥ 1 drink / month       33                 36.6 (19.1; 69.0)   44.4 (21.7; 75.0)      1.3 (-9.4; 21.3)    
  \< 1 drink / month      47                 33.7 (19.0; 73.6)   37.7 (22.5; 72.6)      4.3 (-7.2; 19.6)    
                          **p**                                                                             **0.726**
  **Creatinine**          \< 100 μmol/l      63                  33.8 (19.0; 59.4)      37.6 (20.5; 68.9)   2.7 (-8.1; 19.2)
  ≥ 100 μmol/l            19                 33.0 (16.5; 81.5)   39.9 (21.7; 88.9)      6.6 (-4.5; 17.3)    
                          **p**                                                                             **0.527**

^1^ Median (5^th^-95^th^ percentile);

10.1371/journal.pone.0185404.t006

###### Influence of risk factors on RA lumen changes.

![](pone.0185404.t006){#pone.0185404.t006g}

                                             N                      Arterial lumen volume                           
  ----------------------- ------------------ ---------------------- ----------------------- ----------------------- -----------------------
  **Gender**              Man                65                     404.6 (252.8; 675.9)    321.8 (194.2; 603.8)    -61.6 (-233.2; 87.2)
  Woman                   31                 305.0 (203.1; 503.6)   252.3 (173.7; 445.3)    -53.1 (-192.0; 87.2)    
                          **p**                                                                                     **0.538**
  **Age**                 \< 60              29                     353.0 (173.8; 675.9)    302.4 (198.0; 530.3)    -42.2 (-153.9; 94.0)
  60--69                  38                 367.3 (231.0; 640.5)   310.6 (156.0; 571.6)    -53.5 (-325.3; 133.9)   
  ≥ 70                    29                 353.6 (227.8; 645.3)   271.1 (195.0; 603.8)    -62.6 (-192.0; 8.5)     
                          **p**                                                                                     **0.673**
  **Body-mass index**     \< 25              12                     268.3 (212.7; 566.5)    206.3 (149.1; 498.3)    -60.8 (-126.0; 33.8)
  25--29                  48                 369.1 (228.4; 684.2)   317.2 (194.8; 623.2)    -33.0 (-233.2; 74.9)    
  ≥ 30                    32                 404.5 (231.0; 622.8)   300.5 (201.7; 571.6)    -68.3 (-192.0; 87.2)    
                          **p**                                                                                     **0.123**
  **Hypertension**        Yes                65                     368.9 (234.5; 645.3)    314.2 (194.0; 582.7)    -58.8 (-192.0; 87.2)
  No                      31                 343.5 (173.8; 635.3)   270.3 (175.3; 530.3)    -43.0 (-210.6; 94.0)    
                          **p**                                                                                     **0.922**
  **Dyslipidemia**        Yes                31                     369.2 (228.4; 628.1)    306.9 (175.3; 603.8)    -54.2 (-192.0; 87.2)
  No                      65                 353.0 (227.8; 675.9)   299.5 (194.2; 571.6)    -46.0 (-210.6; 74.9)    
                          **p**                                                                                     **0.947**
  **Diabetes mellitus**   Yes                33                     369.2 (203.1; 628.1)    314.2 (194.2; 571.6)    -58.4 (-157.2; 87.2)
  No                      63                 353.0 (231.0; 675.9)   302.4 (175.3; 582.7)    -46.0 (-233.2; 87.2)    
                          **p**                                                                                     **0.826**
  **Smoking**             Smoker             26                     372.3 (173.8; 675.9)    271.4 (194.2; 521.7)    -58.1 (-198.4; 94.0)
  Former smoker           29                 404.4 (237.0; 628.1)   377.1 (173.7; 603.8)    -60.8 (-210.6; 87.2)    
  Never smoked            39                 337.3 (212.7; 645.3)   306.9 (175.3; 582.7)    -39.1 (-173.4; 87.2)    
                          **p**                                                                                     **0.604**
  **Alcohol**             ≥ 1 drink / week   14                     332.2 (145.4; 790.8)    290.0 (149.1; 521.7)    -62.4 (-519.7; 162.9)
  ≥ 1 drink / month       33                 391.5 (212.7; 675.9)   367.1 (208.4; 645.8)    -60.8 (-183.4; 94.0)    
  \< 1 drink / month      47                 349.5 (228.4; 599.7)   271.1 (175.3; 582.7)    -53.1 (-198.4; 87.2)    
                          **p**                                                                                     **0.637**
  **Creatinine**          \< 100 μmol/l      63                     368.9 (212.7; 640.5)    307.0 (186.1; 538.3)    -53.9 (-192.0; 94.0)
  ≥ 100 μmol/l            19                 338.2 (227.8; 645.3)   287.7 (156.0; 672.1)    -39.1 (-325.3; 87.2)    
                          **p**                                                                                     **0.513**

^1^ Median (5^th^-95^th^ percentile);

10.1371/journal.pone.0185404.t007

###### Influence of duration of catheterization on change of volume (N = 96).

![](pone.0185404.t007){#pone.0185404.t007g}

                                                               Volume increase      Volume decrease      p
  ------------------------------------------------------------ -------------------- -------------------- -------
  **Intima layer**                                                                                       
  Duration of catheterization (in minutes, median (min-max))   50.5 (23.0; 163.0)   47.5 (24.0; 108.0)   0.892
  **Arterial lumen**                                                                                     
  Duration of catheterization (in minutes, median (min-max))   51.0 (24.0; 163.0)   48.0 (23.0; 130.0)   0.346

10.1371/journal.pone.0185404.t008

###### Correlation between duration of catheterization and change of volume (N = 96).

![](pone.0185404.t008){#pone.0185404.t008g}

  Volume change                              r       p
  ------------------------------------------ ------- -------
  **Intima layer**                                   
  Duration of catheterization (in minutes)   0.080   0.436
  **Arterial lumen**                                 
  Duration of catheterization (in minutes)   0.043   0.680

Minority proportion of patients developed opposite trend comparing to the overall result, i.e. intimal volume decrease and lumen size increase. Statistical analysis of the known risk factors showed no statistical difference between groups with different trends in intimal volume changes ([Table 9](#pone.0185404.t009){ref-type="table"}).

10.1371/journal.pone.0185404.t009

###### Comparison of baseline characteristics in patients with decreased and increased volume of intima (N = 96).

![](pone.0185404.t009){#pone.0185404.t009g}

  Characteristics                                  Decrease in volume (N = 32)[^1^](#t009fn001){ref-type="table-fn"}   Increase in volume (N = 64)[^1^](#t009fn001){ref-type="table-fn"}   p
  ----------------------------- ------------------ ------------------------------------------------------------------- ------------------------------------------------------------------- -------
  **Gender**                    Man                24 (75.0%)                                                          41 (64.1%)                                                          0.357
  Woman                         8 (25.0%)          23 (35.9%)                                                                                                                              
  **Age**                                          62.5 (40.8; 76.9)                                                   67.3 (49.1; 81.1)                                                   0.113
  **BMI**                                          28.7 (24.8; 40.1)                                                   28.1 (23.1; 35.4)                                                   0.523
  **Hypertension**              Yes                23 (71.9%)                                                          42 (65.6%)                                                          0.646
  No                            9 (28.1%)          22 (34.4%)                                                                                                                              
  **Dyslipidemia**              Yes                10 (31.3%)                                                          21 (32.8%)                                                          0.999
  No                            22 (68.8%)         43 (67.2%)                                                                                                                              
  **Diabetes mellitus**         Yes                8 (25.0%)                                                           25 (39.1%)                                                          0.254
  No                            24 (75.0%)         39 (60.9%)                                                                                                                              
  **Peripheral vasculopathy**   Yes                0 (0.0%)                                                            4 (6.3%)                                                            0.298
  No                            32 (100.0%)        60 (93.8%)                                                                                                                              
  **Smoking**                   Smoker             8 (26.7%)                                                           18 (28.1%)                                                          0.961
  Former smoker                 10 (33.3%)         19 (29.7%)                                                                                                                              
  Never smoked                  12 (40.0%)         27 (42.2%)                                                                                                                              
  **Alcohol addiction**         ≥ 1 drink / week   6 (20.0%)                                                           8 (12.5%)                                                           0.369
  ≥ 1 drink / month             12 (40.0%)         21 (32.8%)                                                                                                                              
  \< 1 drink / month            12 (40.0%)         35 (54.7%)                                                                                                                              
  **Creatinine (μmol/l)**                          85.0 (68.0; 118.0)                                                  87.5 (51.0; 135.0)                                                  0.601

^1^ N (%) or median (5^th^-95^th^ percentile);

Discussion {#sec012}
==========

In our study, we analysed the effect of the first-in-life TRC in 100 patients, using serial OCT analysis. The results showed significant changes of the vessel in the period of 9 months after the first catheterization. Overall intimal volume increased and lumen size decreased in 9 months, however in both analysis a minority proportion of the patients showed intimal volume decrease and lumen size increase.

Wakeyama et al. used intravascular ultrasound (IVUS) to assess 100 radial arteries for intimal-medial changes in 2002\[[@pone.0185404.ref010]\]. There was intima-media thickening in repeat-TRI patients compared to the first-time TRI patients, especially in the distal radial artery. In 2008, Burris et al. used OCT for graft quality evaluation of the cadaverous radial artery after endoscopic and open harvesting\[[@pone.0185404.ref012]\]. The first OCT study investigating RA changes in vivo was conducted by Yonetsu et al. in 2010\[[@pone.0185404.ref008]\], enrolling 69 patients, dividing them into first-time and repeat-TRC groups. By measuring multiple cross-section areas of the RA, they found intimal areas to be significantly greater in the repeat-TRC RA group. Older time-domain OCT technology (TD-OCT) was used together with longer (16cm) sheath introduction.

In our study, we enrolled solely "TRC-naive" patients. Our results proved previously suggested hypothesis that even uncomplicated and relatively short TRC affects the radial artery as a complex part of the arterial vascular system. Recent publication by Nakata et al.\[[@pone.0185404.ref013]\] proved that 6F sheath insertion into the RA impaired vascular endothelial function the day after the procedure. The impaired changes assessed by reactive hyperemia peripheral arterial tonometry lasted for 6 months. Taken together, Taken together, these results suggest that most of the diagnostic and therapeutic catheterization are associated with negative RA changes during follow-up.

Question remains, what distinguishes the patients with the opposite trend in development, i.e. patients' minority with intimal volume decrease and lumen volume increase. Since we have not found any differences in the risk factor analysis, we can only speculate on the reasons. We could blame unknown genetic factors, operator variability in catheter manipulation or even unmeasured variables like the degree of antiplatelet therapy.

Due to the fact that no other factors have proved to have a strong effect on the radial artery changes, it may be observed that the RA was affected solely by TRC. Recently, a comprehensive review on minimizing RA damage has been published\[[@pone.0185404.ref014]\].

However, in the real-life setting, rather in daily practice, there are numerous and heterogenous factors that can impact RA degree of injury, chronic changes or even patency: different amount of heparin administered in different centers, number of previous transradial catheterization, hydrophilic sheaths, degree of spasm, size of the catheter etc.

Limitations {#sec013}
-----------

The analysis was limited to 54mm, and the OCT was performed only at baseline and 9 month follow-up; therefore, we could not assess the true time-course of post-TRC changes. There are numerous specific variables that could not be controlled, such as degree of catheter manipulation, operator interpersonal variability, number of catheter exchanges etc. However, we showed no correlation of the results with the duration of the catheterization.

Conclusion {#sec014}
==========

The volumetric model of the radial artery lumen and the arterial wall intimal layer after transradial PCI assessed by OCT at baseline and at 9-month follow-up showed a significant effect of transradial catheterization. The intimal layer volume increased significantly, while the volume of the lumen decreased. No significant clinical factors affecting this process have been found.
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